Skip to main content
. 2021 Jan 23;34(2):355–364. doi: 10.1007/s40620-020-00931-w

Table 1.

Clinical and biological characteristics of the cohort at D0

Clinical

Age (years) (n = 153)

 < 40 years (%)

 [40–65] years

 > 65 years (%)

70 [58;81]

7

35

59

Women (n = 153) (%) 39
Weight (n = 130) (kg) 80 ± 17
Height (n = 125) (m) 1.70 [1.62;1.78]
Body Mass index (n = 120) (kg/m2)

 < 18.5 (%)

 [18.5–25] (%)

 [25–30] (%)

 ≥ 30 (%)

28 [24;31]

3

27

43

27

Medical history (n = 153)

Hypertension (%)

Diabetes (%)

Chronic kidney disease (%)

Active cancer (%)

Active smoking (%)

59

43

17

10

5

Intensive Care Unit (%) 22
Severe case (%) 82
Thoracic CT-Scanner staging (n = 151) (%)

 Normal

 Minor (< 10%)

 Mild (10–50%)

 Severe (> 50%)

17

7

61

16

Biological (D0)

C-reactive protein (n = 153) (mg/L)

C-reactive protein > 5 mg/L

81 [38;155]

97%

Leukocytes (n = 153) (/mm3)

>10,100/mm3 (%)

<4600/mm3 (%)

6180 [4650;9060]

19

24

Lymphocytes (n = 151) (/mm3) 860 [655;1155]
Hemoglobin (n = 153) (g/dL) 12.3 [11.2;13.6]
Platelets (n = 153) (× 1000/mm3) 230 [165;301]

Lactate Dehydrogenase (n = 153) (U/L)

> 220 (%)

342 [259;443]

87

D-Dimer (n = 141) (µg/L)

> 500 (%)

1009 [715;1878]

84

Albumin (n = 148) (g/L)

< 32 (%)

34 ± 5

30

Potassium (n = 153) (mmol/L)

> 5.1 (%)

< 2.5 (%)

4.10 ± 0.47

2

9

Sodium (n = 153) (mmol/L)

< 136 (%)

139 [137;142]

14

Calcium (n = 153) (mmol/L)

< 2.2 (%)

2.10 [2.01;2.20]

72

Bicarbonate (n = 145) (mmol/L)

 < 22.1 (%)

 > 31 (%)

25.5 [23.1;27.6]

17

7